Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Endocyte patents

Patents where

Current Assignee

Name

Endocyte

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7601332 Vitamin receptor binding drug delivery conjugates	Patent 7601332 was granted and assigned to Endocyte on October, 2009 by the United States Patent and Trademark Office.		Endocyte	United States Patent and Trademark Office	7601332	October 13, 2009
‌ US Patent 8105568 Vitamin receptor binding drug delivery conjugates	Patent 8105568 was granted and assigned to Endocyte on January, 2012 by the United States Patent and Trademark Office.		Endocyte	United States Patent and Trademark Office	8105568	January 31, 2012
‌ US Patent 7910594 Vitamin-mitomycin conjugates	Patent 7910594 was granted and assigned to Endocyte on March, 2011 by the United States Patent and Trademark Office.		Endocyte	United States Patent and Trademark Office	7910594	March 22, 2011
‌ US Patent 7128893 Vitamin-targeted imaging agents	Patent 7128893 was granted and assigned to Endocyte on October, 2006 by the United States Patent and Trademark Office.		Endocyte	United States Patent and Trademark Office	7128893	October 31, 2006
‌ US Patent 9636413 Conjugates for treating diseases caused by PSMA expressing cells	Patent 9636413 was granted and assigned to Endocyte on May, 2017 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	9636413	May 2, 2017
‌ US Patent 7862798 Vitamin-targeted imaging agents	Patent 7862798 was granted and assigned to Endocyte on January, 2011 by the United States Patent and Trademark Office.		Endocyte	United States Patent and Trademark Office	7862798	January 4, 2011
‌ US Patent 9273091 Processes for preparing tubulysins	Patent 9273091 was granted and assigned to Endocyte on March, 2016 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	9273091	March 1, 2016
‌ US Patent 9499849 Processes for preparing tubulysins	Patent 9499849 was granted and assigned to Endocyte on November, 2016 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	9499849	November 22, 2016
‌ US Patent 9877965 Vitamin receptor drug delivery conjugates for treating inflammation	Patent 9877965 was granted and assigned to Endocyte on January, 2018 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	9877965	January 30, 2018
‌ US Patent 9782493 Conjugates for treating diseases caused by PSMA expressing cells	Patent 9782493 was granted and assigned to Endocyte on October, 2017 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	9782493	October 10, 2017
‌ US Patent 10500286 CCK2R-drug conjugates	Patent 10500286 was granted and assigned to Endocyte on December, 2019 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	10500286	December 10, 2019
‌ US Patent 10500204 Vitamin receptor drug delivery conjugates for treating inflammation	Patent 10500204 was granted and assigned to Endocyte on December, 2019 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	10500204	December 10, 2019
‌ US Patent 9505747 Processes for preparing tubulysin derivatives and conjugates thereof	Patent 9505747 was granted and assigned to Endocyte on November, 2016 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	9505747	November 29, 2016
‌ US Patent 8865126 Vitamin-targeted imaging agents	Patent 8865126 was granted and assigned to Endocyte on October, 2014 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	8865126	October 21, 2014
‌ US Patent 9550734 Bivalent linkers and conjugates thereof	Patent 9550734 was granted and assigned to Endocyte on January, 2017 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	9550734	January 24, 2017
‌ US Patent 8834842 Vitamin-targeted imaging agents	Patent 8834842 was granted and assigned to Endocyte on September, 2014 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	8834842	September 16, 2014
‌ US Patent 10898596 Conjugates for imaging	Patent 10898596 was granted and assigned to Endocyte on January, 2021 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	10898596	January 26, 2021
‌ US Patent 8044200 Synthesis and purification of pteroic acid and conjugates thereof	Patent 8044200 was granted and assigned to Endocyte on October, 2011 by the United States Patent and Trademark Office.		Endocyte	United States Patent and Trademark Office	8044200	October 25, 2011
‌ US Patent 8987281 Methods of treating cancer	Patent 8987281 was granted and assigned to Endocyte on March, 2015 by the United States Patent and Trademark Office.		Endocyte	United States Patent and Trademark Office	8987281	March 24, 2015
‌ US Patent 8043602 Folate targeted enhanced tumor and folate receptor positive tissue optical imaging technology	Patent 8043602 was granted and assigned to Endocyte on October, 2011 by the United States Patent and Trademark Office.		Endocyte	United States Patent and Trademark Office	8043602	October 25, 2011
‌ US Patent 9662402 Drug delivery conjugates containing unnatural amino acids and methods for using	Patent 9662402 was granted and assigned to Endocyte on May, 2017 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	9662402	May 30, 2017
‌ US Patent 8313728 Vitamin-targeted imaging agents	Patent 8313728 was granted and assigned to Endocyte on November, 2012 by the United States Patent and Trademark Office.		Endocyte	United States Patent and Trademark Office	8313728	November 20, 2012
‌ US Patent 9555139 Binding ligand linked drug delivery conjugates of tubulysins	Patent 9555139 was granted and assigned to Endocyte on January, 2017 by the United States Patent and Trademark Office.		Endocyte	United States Patent and Trademark Office	9555139	January 31, 2017
‌ US Patent 9745341 Tubulysins and processes for preparing	Patent 9745341 was granted and assigned to Endocyte on August, 2017 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	9745341	August 29, 2017
‌ US Patent 10010618 Methods for treating cancer using combination therapies	Patent 10010618 was granted and assigned to Endocyte on July, 2018 by the United States Patent and Trademark Office.	Endocyte	Endocyte	United States Patent and Trademark Office	10010618	July 3, 2018

Results per page:

43 results

0 selected

43 results

0 selected